#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type I Bone marrow disorder Immunodeficiency congenital Philadelphia positive chronic myeloid leukaemia Angiosarcoma non-metastatic Aicardi-Goutieres syndrome Endometrial cancer recurrent Adenocarcinoma pancreas Glycogen storage disease type V Squamous cell carcinoma of the vulva Mucous membrane pemphigoid Synovial sarcoma Biliary neoplasm Pseudomyxoma peritonei B-cell small lymphocytic lymphoma More trials…

    Learn about Rare Diseases

    Cystic fibrosis – Life with Disease Retinitis pigmentosa – Treatment Sjogren’s syndrome – Basic Information Glomerulonephritis membranous – Life with Disease Andersen-Tawil syndrome – Diagnostics Lennox-Gastaut syndrome Medulloblastoma – Basic Information Hairy cell leukaemia recurrent – Diagnostics Gaucher’s disease type I Tuberous sclerosis complex – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gskvx000000017033 Tramadol Hydrochloride Df6002 FLUORIDE Gskvx000000008885 Pyruvic Acid Pemetrexed Disodium O15-Water 20-HYDROXYECDYSONE Vemurafenib Betahistine Dihydrochloride Cholic Acid Pevonedistat Lenograstim Nitrogen Abc-35B-116 Ergocalciferol CHOLINE ALFOSCERATE Iopromide Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Behavioural addiction Thrombotic microangiopathy Procedural hypotension Retroperitoneal cancer Endocarditis Postprandial hypoglycaemia Facial paresis Pigmentary glaucoma Anal squamous cell carcinoma Growth hormone deficiency Primary amyloidosis Corticobasal degeneration Osteogenesis imperfecta Sarcoma metastatic Mitochondrial myopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of cc-97540 CD19‑Targeted NEX‑T CAR T in participants with chronic immune thrombocytopenia and autoimmune hemolytic anemia

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • CC-97540
    Denmark Germany

  • Efficacy and safety of roluperidone versus drug combination in adults with schizophrenia with negative symptoms

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Aripiprazole
    • Risperidone
    • Fluoxetine Hydrochloride
    Bulgaria Romania

  • Evaluation of D-Glucose-13C6 Test for Detecting SDHx Mutations in Patients with Pheochromocytoma or Paraganglioma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Paraganglion neoplasm
    • Phaeochromocytoma
    France

  • Effect of Rimonabant on Functional Recovery in Subacute Stroke Patients

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Cerebrovascular accident
    Spain

  • Study of atrasentan in children aged 2 to <18 years with primary IgA nephropathy to evaluate proteinuria reduction, safety and tolerability

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Atrasentan Hydrochloride
    France Spain

  • Topical delgocitinib safety study in patients with cutaneous T‑cell lymphoma (mycosis fungoides)

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cutaneous T-cell lymphoma
    Denmark
Previous Page
1 … 666 667 668 669 670 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!